What is Amphastar Pharmaceuticals's total revenue?

Amphastar Pharmaceuticals (AMPH) reported total revenue of $171.17M in Q1 2026.

How has Amphastar Pharmaceuticals's total revenue changed year-over-year?

Amphastar Pharmaceuticals's total revenue increased by 0.4% year-over-year, from $170.53M to $171.17M.

What is the long-term trend for Amphastar Pharmaceuticals's total revenue?

Over 4 years (2021 to 2025), Amphastar Pharmaceuticals's total revenue has grown at a 13.2% compound annual growth rate (CAGR), from $437.77M to $719.89M.

What does total revenue mean?

The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.

Amphastar Pharmaceuticals AMPH Total Revenue

Total Revenue at other companies

PfizerPFE

$14.45B+5.4%

Halozyme TherapeuticsHALO

$376.71M+42.2%

ViatrisVTRS

$3.52B+8.1%

Opko HealthOPK

$124.2M-17.2%

AptarGroupATR

$982.87M+10.8%

ARS Pharmaceuticals, Inc.SPRY

$22.68M+184%

Segments

By geography

See full

US$159.04M-2.2%

FR$9.65M+22.8%

CN$2.48M+2,964%

By segment

See full

Finished Pharmaceutical Products$171.17M+0.4%

Other financials

Income statement

See full

Gross profit$70.3M-17.5%

Operating income$13.6M-63.5%

Net income$6.4M-74.6%

EPS (diluted)$0.14-72.5%

Balance sheet

See full

Cash & equivalents$170.9M-6.5%

Total debt$686.6M+5.2%

Total equity$445.5M—

Total assets$1.6B+1.3%

Cash flow

See full

Operating cash flow$47.8M+36.4%

CapEx$9.5M-11.1%

Free cash flow$38.3M+57.2%

Valuation

See full

Market cap$926.83M-19.9%

Enterprise value$1.44B-11.4%

P/E11.7×+3.5×

P/S1.3×-0.3×

Profitability

See full

Gross margin47.3%-3.2pp

Operating margin16.2%-10.4pp

Net margin11%-8.4pp

FCF margin18.8%-1.8pp

Returns & leverage

See full

Return on equity14.7%—

Debt / equity0.2×—

Current ratio3.9×+0.9×

Where this comes from

Reported directly by Amphastar Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:Revenues.

The official record: Amphastar Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Amphastar Pharmaceuticals's total revenue.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Amphastar Pharmaceuticals's total revenue?: Amphastar Pharmaceuticals (AMPH) reported total revenue of $171.17M in Q1 2026.
How has Amphastar Pharmaceuticals's total revenue changed year-over-year?: Amphastar Pharmaceuticals's total revenue increased by 0.4% year-over-year, from $170.53M to $171.17M.
What is the long-term trend for Amphastar Pharmaceuticals's total revenue?: Over 4 years (2021 to 2025), Amphastar Pharmaceuticals's total revenue has grown at a 13.2% compound annual growth rate (CAGR), from $437.77M to $719.89M.
What does total revenue mean?: The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.